Public (anyone can view and join)

In recent years, blue light therapy has gained popularity as a non-invasive treatment for a range of conditions, from acne to seasonal affective disorder. But how does this type of therapy work? In this article, we'll take a closer look at the science behind blue light therapy and explore its potential benefits.

How It Works:

Blue light therapy involves exposing the skin or eyes to a specific wavelength of blue light, typically between 405 and 420 nanometers. This type of light is thought to penetrate the skin or eyes and stimulate the production of reactive oxygen species (ROS), which can help kill bacteria and reduce inflammation.

In the case of acne treatment, blue light therapy targets the bacteria that cause acne, known as Propionibacterium acnes. When exposed to blue light, these bacteria produce a molecule called porphyrin, which can absorb the light and create ROS that damage the bacteria's DNA, ultimately killing them.

Blue light therapy has also been shown to be effective in treating seasonal affective disorder (SAD), a type of depression that is thought to be caused by a lack of sunlight exposure. By mimicking the effects of natural sunlight, blue light therapy can help regulate circadian rhythms and boost serotonin levels, improving mood and reducing symptoms of SAD.

In addition to its potential benefits for acne and SAD, blue light therapy is also being studied as a treatment for other conditions, such as psoriasis, eczema, and sleep disorders.


Blue light therapy is a promising non-invasive treatment option for a range of conditions, from acne to seasonal affective disorder. By stimulating the production of reactive oxygen species, blue light can help kill bacteria and reduce inflammation, ultimately improving skin health and regulating circadian rhythms. While further research is needed to fully understand its mechanisms of action and potential benefits, blue light therapy shows great potential as a safe and effective treatment option.

Recent Activities

There are no new feeds to view at this time.